The latest price target for Medical Properties Trust (NYSE:MPW) was reported by Exane BNP Paribas on July 2, 2024. The analyst firm set a price target for $4.00 expecting MPW to fall to within 12 months (a possible -11.89% downside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Medical Properties Trust (NYSE:MPW) was provided by Exane BNP Paribas, and Medical Properties Trust downgraded their neutral rating.

The last upgrade for Medical Properties Trust Inc happened on April 17, 2024 when Deutsche Bank raised their price target to $5. Deutsche Bank previously had a sell for Medical Properties Trust Inc.

The last downgrade for Medical Properties Trust Inc happened on July 2, 2024 when Exane BNP Paribas changed their price target from $6 to $4 for Medical Properties Trust Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medical Properties Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medical Properties Trust was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.

While ratings are subjective and will change, the latest Medical Properties Trust (MPW) rating was a downgraded with a price target of $6.00 to $4.00. The current price Medical Properties Trust (MPW) is trading at is $4.54, which is out of the analyst’s predicted range.